OpenRx Open Medications Explorer
© 2026 OpenRx · public-domain U.S. government data
On this page

Extavia

interferon beta-1b

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Extavia
Proper name
interferon beta-1b
Licence type
351(a)
BLA number
125290
Applicant
Novartis Pharmaceuticals Corporation
Center
CDER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
0.3MG For Injection Subcutaneous Single-Dose Vial Disc August 14, 2009

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity